Table 1.
Treatment | Stage | No. of Embryos/Larvae | Min. No. of PGCs | Max. No. of PGCs | Mean | SD | p *** |
---|---|---|---|---|---|---|---|
Control | Neurula | 29 | 12 | 86 | 44.14 | 21.04 | 0.006679 |
22 dpf | 14 | 12 | 41 | 26.57 | 10.30 | ||
150/200 ** | Neurula | 30 | 0 | 20 | 7.23 | 5.85 | 0.00616 |
22 dpf | 20 | 0 | 12 | 5.90 | 4.78 | ||
200/200 ** | Neurula | 21 | 0 | 19 | 6.90 | 6.94 | 0.9672 |
22 dpf | 19 | 0 | 12 | 3.68 | 4.06 | ||
250/150 ** | Neurula | 21 | 0 | 21 | 7.23 | 6.70 | 0.6031 |
22 dpf | 18 | 0 | 15 | 5.22 | 4.85 |
** sgRNA/Cas9 Concentrations in ng/µl; *** Wilcoxon test